Emergency Use Listing by WHO
E523136
World Health Organization program
emergency use authorization mechanism
regulatory procedure
risk-based assessment procedure
Emergency Use Listing by WHO is a World Health Organization risk-based procedure that expedites the assessment and authorization of unlicensed vaccines, medicines, and diagnostics for use during public health emergencies.
All labels observed (4)
| Label | Occurrences |
|---|---|
| Emergency Use Listing by WHO canonical | 1 |
| Emergency Use Listing procedure | 1 |
| WHO Emergency Use Listing | 1 |
| World Health Organization Emergency Use Listing | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T5481698 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Emergency Use Listing by WHO Context triple: [COVID-19 vaccines, regulatoryApproval, Emergency Use Listing by WHO]
-
A.
Public Health Emergency of International Concern
A Public Health Emergency of International Concern is a formal WHO designation for an extraordinary health event that poses a public health risk to multiple countries and may require a coordinated international response.
-
B.
World Health Organization Model List of Essential Medicines
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
-
C.
COVID-19 pandemic
The COVID-19 pandemic is a global outbreak of the coronavirus SARS-CoV-2 that began in late 2019, causing widespread illness, deaths, and major disruptions to societies and economies worldwide.
-
D.
WHO Emergency Committee
The WHO Emergency Committee is a group of international public health experts convened by the World Health Organization to assess serious disease outbreaks and advise on whether they constitute a global health emergency.
-
E.
Ministry of Health of the DRC Ebola response
The Ministry of Health of the DRC Ebola response is the national public health authority’s coordinated program to detect, contain, and manage Ebola outbreaks across the Democratic Republic of the Congo.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Emergency Use Listing by WHO Target entity description: Emergency Use Listing by WHO is a World Health Organization risk-based procedure that expedites the assessment and authorization of unlicensed vaccines, medicines, and diagnostics for use during public health emergencies.
-
A.
Public Health Emergency of International Concern
A Public Health Emergency of International Concern is a formal WHO designation for an extraordinary health event that poses a public health risk to multiple countries and may require a coordinated international response.
-
B.
World Health Organization Model List of Essential Medicines
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
-
C.
COVID-19 pandemic
The COVID-19 pandemic is a global outbreak of the coronavirus SARS-CoV-2 that began in late 2019, causing widespread illness, deaths, and major disruptions to societies and economies worldwide.
-
D.
WHO Emergency Committee
The WHO Emergency Committee is a group of international public health experts convened by the World Health Organization to assess serious disease outbreaks and advise on whether they constitute a global health emergency.
-
E.
Ministry of Health of the DRC Ebola response
The Ministry of Health of the DRC Ebola response is the national public health authority’s coordinated program to detect, contain, and manage Ebola outbreaks across the Democratic Republic of the Congo.
- F. None of above. chosen
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
World Health Organization program
ⓘ
emergency use authorization mechanism ⓘ regulatory procedure ⓘ risk-based assessment procedure ⓘ |
| administeredBy | World Health Organization ⓘ |
| appliesTo |
in vitro diagnostics
ⓘ
medical devices for public health emergencies ⓘ medicines ⓘ vaccines ⓘ |
| basedOn |
review of quality, safety and efficacy data
ⓘ
risk–benefit assessment ⓘ |
| beneficiary | countries with limited regulatory capacity ⓘ |
| criterion |
potential benefits must outweigh potential risks
ⓘ
public health emergency of international concern or similar emergency context ⓘ |
| developedBy | World Health Organization ⓘ |
| differentFrom | full marketing authorization by national regulatory authorities ⓘ |
| enables | emergency procurement of listed products ⓘ |
| geographicScope | global ⓘ |
| hasAbbreviation | EUL ⓘ |
| hasLanguage | English ⓘ |
| hasOfficialName |
Emergency Use Listing procedure
ⓘ
linked to:
Emergency Use Listing by WHO
|
| hasStakeholder |
United Nations procurement agencies
ⓘ
linked to:
United Nations Office for Project Services
diagnostic manufacturers ⓘ global health partners ⓘ national regulatory authorities ⓘ vaccine manufacturers ⓘ |
| includesStep |
WHO scientific review of available data
ⓘ
assessment of clinical performance ⓘ assessment of manufacturing quality ⓘ post-listing monitoring requirements ⓘ submission of product dossier by manufacturer ⓘ |
| legalNature | non-binding recommendation to Member States ⓘ |
| monitoredBy | World Health Organization ⓘ |
| purpose |
to expedite assessment of unlicensed health products during public health emergencies
ⓘ
to facilitate availability of quality, safe and effective products during emergencies ⓘ |
| relatedConcept | Emergency Use Authorization ⓘ |
| relatedTo | WHO prequalification program ⓘ |
| requires |
commitment to continue generating data
ⓘ
good manufacturing practice compliance ⓘ risk management plan ⓘ |
| supports |
Member States regulatory decisions
ⓘ
UN procurement agencies ⓘ |
| supportsGoal | rapid access to essential medical products in emergencies ⓘ |
| timeLimited | true ⓘ |
| usedDuring | public health emergencies ⓘ |
| usedFor |
COVID-19 in vitro diagnostic tests
ⓘ
COVID-19 therapeutics ⓘ COVID-19 vaccines ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Emergency Use Listing by WHO Description of subject: Emergency Use Listing by WHO is a World Health Organization risk-based procedure that expedites the assessment and authorization of unlicensed vaccines, medicines, and diagnostics for use during public health emergencies.
Referenced by (4)
Full triples — surface form annotated when it differs from this entity's canonical label.
Vaxzevria COVID-19 vaccine
→
hasRegulatoryApproval
→
World Health Organization Emergency Use Listing
ⓘ
linked to: Emergency Use Listing by WHO
linked to: Emergency Use Listing by WHO
linked to: Emergency Use Listing by WHO